Please Wait.....
Report
Human Reproductive Technologies: Products and Global Markets
Market Research Report I 2022-07-29 I 193 Pages I BCC Research
Description
Report Scope:
The report is designed to be a comprehensive business tool to provide an in-depth look at the markets for reproductive drugs and technologies. The geographic scope of the report is global. The report reviews male and female reproductive health, presents standard pharmaceutical treatments and devices, and reviews technologies associated with reproductive health. The report also explores market size, identifies market participants, and investigates pipeline products and technologies.
The global market for reproductive technologies and products is divided into categories by treatment type and indication as follows.
Infertility market - male and female factors, pharmaceuticals, and future advancements.
- IVF.
- Assistive reproductive technologies.
- Fertility diagnostics.
Contraception - pharmaceuticals and devices.
Sexual dysfunction - pharmaceuticals and devices.
Each area is covered in detail, describing the disorder or treatment involved, identifying current products and treatments in the market in the base year 2021, measuring current market size and identifying current and potential market drivers, forecasting for 2027, assessing current and potential competitors, and identifying current competitor market shares for the base year of 2021.
Report Includes:
- 36 data tables and 22 additional tables
- An updated review of the global markets for human reproductive products and technologies
- Analyses of the global market trends, with data from 2020-2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2027
- Evaluation and forecast the overall market size, projected growth trends, and corresponding market share analysis by treatment type, disease indication, end-user vertical, and geographic region
- In-depth information (facts and figures) concerning market drivers, market deterrents and other demographic and economic factors influencing the progress of this reproductive health market
- Discussion of the emerging technology trends, opportunities and gaps in the market estimating current and future demand for reproductive drugs and technologies, and COVID-19 implications within the marketplace
- Identification of promising new products and technologies still in the development and pipeline stage, and assess the probability that they will be commercialized successfully in the next five years
- Review of the company competitive landscape for global human reproductive drugs market, their product portfolios, global rankings, and company value share analysis based on segmental revenues
- Key merger and acquisition deals, new product launches, and other strategic alliances within the industry
- A relevant patent analysis
- Descriptive company profiles of the leading global players, including Actavis,Inc., Bayer AG, EMD Serono,Inc. and Quidel Corp.
Executive Summary
Summary:
Many factors influence the human reproductive arena. Countries differ in their approaches and acceptance of fertility, contraception, and sexual dysfunction. Culture, religion, and social environment all play a role; depending on the country and position of women in the society, it can make a huge difference on how reproduction is treated. The choice of contraception varies by country: in Japan, condoms and abortions are preferred to other methods; in India, sterilization is the preferred method of birth control; in China, the use of the coil is preferred; while in Africa, injectable birth control dominates. This difference in preference by country is also seen in the fertility and sexual dysfunction areas.
There have been increasing investments and advancements in each of the three major areas of infertility, contraception, and sexual dysfunction. The total market for reproductive technologies and products was estimated at nearly $REDACTED billion in 2021. In 2027, the forecasted revenues will likely reach $REDACTED billion, demonstrating an average annual growth rate of REDACTED%.
One of the most widely publicized, celebrated and, at the time, controversial medical landmarks in this area is the use of assisted reproductive technology (ART) to manage infertility. Recent developments in the field of ART have intensified the hopes and the wishes of infertile people to resolve their infertility, resulting in an increasing demand for such services in both developed and developing countries. While developments in ART have evolved rapidly, so have the ethical, social, and political controversies that surround nearly all aspects of ART. Few other areas in medicine have posed so many social and ethical questions and attracted so much public attention. Cultural differences influence the acceptance of ART.
In addition, economic forces play a role in this market because it is an expensive undertaking that is not affordable to many. In Asia, the doors seem to be opening for growth, but there are barriers to overcome such as educating physicians and patients about the procedures and social and culture mores that influence ART.
New developments in the area of contraception have stepped up the quest for easier, safer, and more convenient methods of contraception. There is no miracle drug or method of contraception, but scientists are pursuing several avenues of discovery to create better options for individuals. Contraceptive products currently account for the highest amount of revenues and are expected to grow at a CAGR of REDACTED% through the forecast period.
Sexual dysfunction is now an acknowledged disorder by the general public and the medical community. Prior to the advent of Viagra, the disorder was present but not acknowledged and largely went untreated. The introduction of Viagra opened Pandora's box in the development of sexual dysfunction drugs and devices for both sexes, at a time when female sexual dysfunction was virtually unknown. This area of reproductive health is teeming with opportunities for research and discovery and will likely continue to advance over the next few years, but progress has been slow, and some ED products are open to generic development. Sexual dysfunction products are expected to show annual growth on average of REDACTED% between 2022 an d 2027.
Table of Contents
Chapter 1 Introduction
Study Goals and Objectives
Reasons for Doing This Study
What's New in This Update?
Scope of Report
Methodology
Information Source
Geographic Breakdown
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports
Chapter 2 Summary and Highlights
Introduction
Chapter 3 Industry Overview
Structure and Function of the Reproductive System
Male
Female
Neuroendocrine Regulation
Menarche
Menstruation Cycle
Phases of Sexual Responses
Male Sexual Response
Female Sexual Response
Neurohormonal Control of the Female and Male Reproductive System
Effects of Aging
Issues and Trends of Reproductive Health
Contraceptive Insurance
Over-the-Counter Birth Control Pills
Pre-Implantation Genetic Diagnosis
Designer Babies
New Use for Contraceptives
Aging and Infertility
Death by Contraceptive Patch
Sexual Dysfunction and Cancer
Infertility and Cancer
Signaling Pathway for Fertility Treatment
Marketing Tactics
Male Birth Control
Merchandising Targeting Women
Counterfeit Products
Surplus Embryos and Fetuses
Stem Cell and Other Controversial Issues - Selected International Views
Controversial Disposal of Embryos
Demographics
Chapter 4 Infertility Market
Introduction and Overview of Infertility
Definition of Infertility
Etiology of Infertility
Evaluation of Fertility
Unexplained Infertility
Multiple Births
Asia Factor
Chapter 5 COVID-19 Impact
Introduction
COVID-19: Impact on the Medical Devices and Pharma Industries
Decline/Delay in Elective Procedures
COVID-19 Impact on Supply Chain
U.S. Supply Chain: COVID-19 Impact
European Supply Chain: COVID-19 Impact
APAC Supply Chain: COVID-19 Impact
China: COVID-19 Impact
COVID-19 Impact on Medical Device and Pharmaceutical Product Segments
COVID-19 Impact on Critical Devices
COVID-19 Impact on Human Reproductive Technologies and Products Markets
Chapter 6 Methods of Treatment
Fertility Pharmaceuticals
Introduction and Types
Market Revenues and Forecast
Future Advancements in Infertility Products
Competitive Analysis
Chapter 7 Assistive Reproductive Technologies
Introduction
Types
IVF
Ovulation Induction
Oocyte Retrieval
Intracytoplasmic Sperm Injection (ICSI)
Fertilization
Embryo Transfer
Results of IVF
GIFT
ZIFT
Wombs for Rent
Oocyte Donation
Frozen Embryos
United States Fertility Clinics
Market Revenues and Forecast
Future Trends in Assistive Reproductive Technology
Competitive Analysis
Chapter 8 Fertility Diagnostics
Introduction
Types
Urine Studies
Market Revenues and Forecast
Competitive Analysis
Future Advancements in Diagnostic Fertility Treatment
Total Infertility Market Revenues and Forecast
Chapter 9 Contraception Market
Introduction and Overview of Contraception
Pharmaceuticals
Types
Other Drug Regimens for Contraception
Market Revenues and Forecast
Competitive Analysis
Prescription Devices
Market Revenues and Forecast
Competitive Analysis
Future Advancements in Contraception
Total Market Revenues and Forecast
Chapter 10 Sexual Dysfunction Market
Introduction and Overview
Types of Sexual Dysfunction
Causes of Sexual Dysfunction
Demographics of Sexual Dysfunction
Pharmaceuticals
Introduction and Types
Market Revenues and Forecast
Competitive Analysis
Devices
Market Revenues and Forecast
Future Advancements in Sexual Dysfunction
Total Market Revenues and Forecast
Chapter 11 Patents
Patent Analysis by Manufacturer
Patent by Company
Patents by Application
Infertility Treatments
Contraception
Sexual Dysfunction
Leading Market Manufacturers
Chapter 12 Total Market
Total Global Market for Reproductive Technologies and Products, by Region
North America
Europe
Asia-Pacific
Rest of the World
Total Market Size by Category
Industry Participants by Category
Total Market Size by Product Type
Chapter 13 Competitive Landscape
Competitive Analysis
Chapter 14 Company Profiles
ACTAVIS, INC.
BAYER AG
BRISTOL-MYERS SQUIBB CO.
CHURCH & DWIGHT COMPANY INC.
COOPERSURGICAL INC.
ELI LILLY & CO.
EMD SERONO, INC.
FERRING PHARMACEUTICALS
GLAXOSMITHKLINE PLC
JANSSEN PHARMACEUTICAL
MERCK INC.
NOVARTIS INTERNATIONAL AG
PFIZER INC.
PRINCETON BIOMEDITECH CORP.
QUIDEL CORP.
TEVA PHARMACEUTICALS.
VIVUS INC.
Selected List of U.S. Fertility Clinics
List of Companies
Chapter 15 Appendix: Acronyms
List of Tables
Summary Table : Global Market for Human Reproductive Technologies and Products, by Product Type, Through 2027
Table 1 : Structural Homologues of the Male and Female Reproductive Systems
Table 2 : U.S. Live Birth Rates, 2000-2020
Table 3 : U.S. Population, by Selected Age Groups, and by Percent of Total Population, 2010-2030
Table 4 : Characteristics of Women Who Have Had a Child in the Last Year, 2008 and 2010
Table 5 : Women Who Have Had a Child in the Last Year, by Age and Labor FORCE Status, 1980-2008
Table 6 : Contraceptive Use Share, by Type, by Age, Ethnic Group and Marital Status
Table 7 : Birth Rate in Europe, by Country and Year, 1960-2020
Table 8 : Selected Prescription Fertility Drugs
Table 9 : Global Infertility Pharmaceuticals Market, Through 2027
Table 10 : Infertility Drugs in Development
Table 11 : Global Infertility Pharmaceutical Manufacturer Market, 2021
Table 12 : National Summary of Assistive Reproductive Therapies in U.S., 2020
Table 13 : National Assistive Reproductive Therapies Cycle Profile, 2019
Table 14 : Pregnancy Success Rates, 2019
Table 15 : Number of IVF Clinics/Centers by Selected Countries
Table 16 : Global Assistive Reproductive Technologies Market, Through 2027
Table 17 : Global Infertility Assistive Reproductive Products Manufacturer Market, 2021
Table 18 : Global Fertility Diagnostics Market, by Product Type, Through 2027
Table 19 : Global Fertility Diagnostic Manufacturer Market, 2021
Table 20 : Global Infertility Treatments Market, by Product Type, Through 2027
Table 21 : Contraceptive Status and Use Rates, U.S. Women Aged 15-49, 2015-2017
Table 22 : Contraceptive Use, by Region, 2015 and 2030
Table 23 : Most Commonly Used Oral and Transdermal Contraceptives
Table 24 : Estrogen and Progestin Hormone Doses in Combined Birth Control Pills
Table 25 : Potency of Different Oral Contraceptive Progestins
Table 26 : Current Pill Problems and Choice of Pill to Switch To
Table 27 : Global Contraceptive Pharmaceuticals Market, by Product Type, Through 2027
Table 28 : Global Contraceptive Pharmaceutical Manufacturer Market, 2021
Table 29 : Selected Contraceptive Device Treatments, 2021
Table 30 : Global Contraceptive Devices Market, by Product Type, Through 2027
Table 31 : Global Contraceptive Device Manufacturer Market, 2021
Table 32 : Contraceptives in Development
Table 33 : Global Contraceptive Products Market, by Product Type, Through 2027
Table 34 : Selected Sexual Dysfunction Pharmaceutical Treatments
Table 35 : Global Sexual Dysfunction Pharmaceuticals Market, by Product Type, Through 2027
Table 36 : Global Sexual Dysfunction Pharmaceuticals Manufacturer Market, 2021
Table 37 : Selected Sexual Dysfunction Device Treatments
Table 38 : Global Sexual Dysfunction Devices Market, by Product Type, Through 2027
Table 39 : Global Sexual Dysfunction Devices Manufacturer Market, 2021
Table 40 : Sexual Dysfunction Drugs in Development
Table 41 : Global Sexual Dysfunction Treatments Market, by Product Type, Through 2027
Table 42 : Selected Manufacturer Patents for Reproductive Products and Related Technology, by Application, 2015-Present
Table 43 : Selected Manufacturer Patents for Reproductive Products and Related Technology, by Application, 1976-Present
Table 44 : Patent Analysis, by Selected Leading Reproductive Treatment Manufacturer, 1976-Present
Table 45 : Global Reproductive Technologies and Products Market, Through 2027
Table 46 : Global Reproductive Technologies and Products Market, by Region, Through 2027
Table 47 : North American Reproductive Technologies and Products Market, by Country, Through 2027
Table 48 : European Reproductive Technologies and Products Market, by Country, Through 2027
Table 49 : Asia-Pacific Reproductive Technologies and Products Market, by Country, Through 2027
Table 50 : RoW Reproductive Technologies and Products Market, Through 2027
Table 51 : Global Reproductive Technologies and Products Market, by Region, 2021
Table 52 : Global Reproductive Technologies and Products Market, by Region, 2027
Table 53 : Global Reproductive Technologies and Products Market, by Product Type, Through 2027
Table 54 : Global Reproductive Technologies and Products Market, 2019
Table 55 : Reproductive Industry Participants, by Product Category
Table 56 : Global Reproductive Technologies and Products Market, by Product Type, Through 2017
Table 57 : List of Companies
Table 58 : Acronyms Used in This Report
List of Figures
Summary Figure A : Global Market for Human Reproductive Technologies and Products, by Product Type, 2019-2027
Summary Figure B : Global Market Share of Human Reproductive Technologies and Products, by Product Type, 2021
Figure 1 : U.S. Live Birth Rates, 2000-2020
Figure 2 : U.S. Population Selected Age Groups, by Percent of Total Population, 2010-2030
Figure 3 : Global Infertility Pharmaceutical Manufacturer Market Share, 2021
Figure 4 : Global Infertility Assistive Reproductive Products Manufacturer Market Share, 2021
Figure 5 : Global Fertility Diagnostic Manufacturer Market Share, 2021
Figure 6 : Global Infertility Treatments Market, by Product Type, 2019-2027
Figure 7 : Global Contraceptive Pharmaceuticals Manufacturer Market Share, 2021
Figure 8 : Global Contraceptive Device Manufacturer Market Share, 2021
Figure 9 : Global Contraceptive Products Market, by Product Type, 2019-2027
Figure 10 : Global Sexual Dysfunction Pharmaceuticals Manufacturer Market Share, 2021
Figure 11 : Global Sexual Dysfunction Devices Manufacturer Market Share, 2021
Figure 12 : Global Sexual Dysfunction Treatments Market, by Product Type , 2019-2027
Figure 13 : Global Reproductive Technologies and Products Market Share, by Region, 2021
Figure 14 : Global Reproductive Technologies and Products Market Share, by Region, 2027
Figure 15 : Global Reproductive Technologies and Products Market, by Product Type, 2019-2027
Figure 16 : Number of Selected Manufacturers, by Segment, 2019
Figure 17 : Global Reproductive Technologies and Products Market Share, 2019
Figure 18 : Global Reproductive Technologies and Products Market, by Product Type, 2019-2027
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security